Immunology

Improving the efficacy of cellular therapies

Researchers have gained a better understanding of the complexity of the environment in which T cells thrive and, by extension, the tolerance mechanisms of these cells which are an obstacle to cellular immunity.

Immunology

Beating HIV and COVID-19 may depend on tweaking vaccine molecules

Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which ...

Diseases, Conditions, Syndromes

COVID-19 cases, deaths may follow weekly pattern

MIT, Boston University, and Harvard Medical School researchers have identified weekly oscillations in the numbers of new daily COVID-19 cases and deaths in several countries that are more pronounced than fluctuations seen ...

Diseases, Conditions, Syndromes

Malaria discovery could expedite antiviral treatment for COVID-19

The study, conducted by an international team and led by RMIT University's Professor Christian Doerig, outlines a strategy that could save years of drug discovery research and millions of dollars in drug development by repurposing ...

Diseases, Conditions, Syndromes

A coronavirus vaccine may require boosters – here's what that means

In the global race to contain the coronavirus pandemic, there is hopeful news on the vaccine front, with a number of potential candidates being developed and some promising early results. Based on what we know so far, it ...

Diseases, Conditions, Syndromes

Smokers, vapers in special danger from coronavirus

(HealthDay)—Smokers and vapers who get COVID-19 are more likely to have complications, so this might be a good time to quit, the Society of Thoracic Surgeons says.

page 1 from 8